| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 5605577 | International Journal of Cardiology | 2017 | 5 Pages |
Abstract
In this analysis of well-treated HF patients, digoxin was associated with increased ACM. Further randomized controlled trials are needed to determine whether digoxin therapy should be used in well-treated HF patients. Until then, routine use of digoxin in clinical practice should be discouraged.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
May Al-khateeb, Waqas T. Qureshi, Raed Odeh, Amjad M. Ahmed, Sherif Sakr, Radwa Elshawi, M. Bassam Bdeir, Mouaz H. Al-Mallah,